FDA.reportPublic FDA data

insulin analog, glargine 300 UNT Pen Injector

RxCUI
847230
RxNorm name
insulin analog, glargine 300 UNT Pen Injector
Display name
insulin analog, glargine 300 UNT Pen Injector
Full name
insulin analog, glargine 300 UNT Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
021081Lantusinsulin glargine351(a)Rx2026-07-01
205692Basaglarinsulin glargine351(a)Disc2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BASAGLAR KwikPenINSULIN GLARGINEEli Lilly and Company0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae2026-06-16Warnings, Adverse reactionsExact identifier
rxcui: 847230
Lantus SolostarINSULIN GLARGINEsanofi-aventis U.S. LLCd5e07a0c-7e14-4756-9152-9fea485d654a2025-06-02Warnings, Adverse reactionsExact identifier
rxcui: 847230
Insulin Glargine SolostarINSULIN GLARGINEA-S Medication Solutions9835904f-64f5-42b3-9ac9-89e4aaa5182a2023-11-01Warnings, Adverse reactionsExact identifier
rxcui: 847230
LANTUS SOLOSTARINSULIN GLARGINEA-S Medication Solutions3a97c40f-0c83-42d7-a8ee-484b208db4e32023-07-22Warnings, Adverse reactionsExact identifier
rxcui: 847230
Lantus SolostarINSULIN GLARGINEA-S Medication Solutions632d9f68-f184-43d5-b184-a3af23f12ad92023-06-06Warnings, Adverse reactionsExact identifier
rxcui: 847230

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d5e07a0c-7e14-4756-9152-9fea485d654ainsulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]535These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS ® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 200020250602
0ad21db3-2b1c-4ed9-a687-bdd6a74d0aaeinsulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]534These highlights do not include all the information needed to use BASAGLAR safely and effectively. See full prescribing information for BASAGLAR BASAGLAR (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 201520251211
632d9f68-f184-43d5-b184-a3af23f12ad9insulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]513These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS ® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 200020230606
3a97c40f-0c83-42d7-a8ee-484b208db4e3insulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]56These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS ® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 200020230722
9835904f-64f5-42b3-9ac9-89e4aaa5182ainsulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]53These highlights do not include all the information needed to use Insulin glargine safely and effectively. See full prescribing information for Insulin glargine. Insulin glargine injection, for subcutaneous injection Initial U.S. Approval: 200020231101
b861fdd9-e134-436e-8c0c-a60dd0006dd3insulin glargine 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin glargine 100 UNT/ML Pen Injector [SCD] · 3 ML insulin analog, glargine 100 UNT/ML Pen Injector [SY] · insulin analog, glargine 300 UNT Pen Injector [SY] · insulin glargine 300 UNT per 3 ML Pen Injector [SY]52These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 200020100105